Human melanoma cell lines differ in their capacity to release ADP and aggregate platelets.
In this study we have investigated, using three different human melanoma cell lines (M1Do., M3Da., M4Be.). the varying capacity of melanoma cells to induce platelet aggregation in the presence or absence of inhibitors of ADP or thrombin. The expression levels of different integrins (alpha v, beta 3, alpha v beta 3, alpha IIb, alpha v beta 3) were evaluated by immunoprecipitation, binding and flow cytometry studies. The level of ADP in supernatants of melanoma cells were quantified by ADP bioassay and HPLC. Platelets were irreversibly aggregated by M3Da, as shown by electron microscopy, in contrast to M1Do, which induced a slow reversible aggregation. M4Be. did not induce platelet aggregation. In both cases, with M3Da. or M1Do., apyrase but not PPACK inhibited platelet induced aggregation. An anti-alpha v beta 3 monoclonal antibody (LYP18) or polyclonal antibody inhibited platelet aggregation. A similar number of LYP18 molecules bound to the surface of M1Do., M3Da. and M4Be. cell lines. Biological HPLC assays of ADP present in the supernatant of tumour cell lines showed the highest concentration of ADP to be secreted by M3Da., followed by M1Do., and none detected for M4Be. These results show that differences in in vitro aggregating potential of the three human melanoma cell lines are not related to low integrin expression levels but to their ability to generate ADP. Generation of ADP by human melanoma cells may act as important modulator of melanoma-platelet interactions.
Boukerche
H
H
INSERM U331, Faculty of Medicine Alexis Carrel, France.
Berthier-Vergnes
O
O
Penin
F
F
Tabone
E
E
Lizard
G
G
Bailly
M
M
McGregor
J L
JL
D000244:Adenosine Diphosphate / Q000096:biosynthesis* / Q000502:physiology; D002851:Chromatography, High Pressure Liquid; D006801:Humans; D016023:Integrins / Q000032:analysis; D008545:Melanoma / Q000378:metabolism* / Q000648:ultrastructure; D008854:Microscopy, Electron; D010974:Platelet Aggregation / Q000502:physiology*; D016024:Receptors, Cytoadhesin / Q000032:analysis; D019030:Receptors, Vitronectin; D014407:Tumor Cells, Cultured
D016023:Integrins; D016024:Receptors, Cytoadhesin; D019030:Receptors, Vitronectin; D000244:Adenosine Diphosphate